Breast cancer can be combated with generics

• April 25, 2024

Patients who have some chronic-degenerative diseases such as Cancer of breast, ovaries, lung, as well as respiratory problems such as asthma , heart attacks and angina of chest, they will be able to fight them with the new generic 29 that the Health Secretary (SSA).

The federal agency delivered the records to produce this type of medicine corresponding to four active substances that are: Docetaxel, Montelukast, Clopidogrel and the Cisatracurium.

According to the Secretary of Health, Solomon Chertorivski Woldenberg , this is the third package of generic drugs released, which aims to ensure the full supply of medicines with the same quality and at a lower price, because this program seeks savings of three thousand 808 million pesos in four years.

According to information published by excelsior.com.mx With this latest release, nine more options will be available in the market for the treatment of various types of Cancer : breast, ovary, lung, prostate and gastric; 11 to treat the asthma , the rhinitis allergic and dermatitis atopic; eight to prevent clots or thrombi and one more that is used as an anesthetic in patients with kidney dysfunction or hepatic .

On the other hand, Mikel Arriola , holder of the Cofepris , indicated that the drugs are equivalent in quality, safety and efficacy to innovators, so it was decided to approve them after the expiration of the patent.

In the next video, the president of the National Association of Pharmacies , Antonio Pascual , explains what is an innovative drug and generic.

The specialist explains that in Mexico, generic drugs are known as interchangeable, because they have the same active substance as the innovative and the same therapeutic effect. And you, what do you prefer branded or interchangeable drugs?

Follow us on Twitter Y Facebook .

If you are interested in receiving more information on this topic, do not hesitate register with us.

Video Medicine: Femara - Letrozle (April 2024).